Cost effectiveness of statins for the secondary prevention of coronary heart disease in Ireland

Ir Med J. 2002 May;95(5):133-5.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Coronary Disease / economics*
  • Coronary Disease / prevention & control*
  • Cost-Benefit Analysis
  • Female
  • Health Care Costs
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Ireland
  • Male
  • Markov Chains
  • Quality-Adjusted Life Years

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors